HPV Vaccine May Prevent Recurrence of Precancerous Conditions

PHOTO: An HPV vaccination is administered in this September 21, 2011 file photo. A study found the vaccine may offer additional prevention benefits.
Share
Copy

The human papillomavirus (HPV) vaccine has been touted as a way to prevent cervical cancer and genital warts, but a new study suggests the vaccine may also prevent women diagnosed with precancers from developing recurrences.

Researchers randomly assigned more than 1,350 women diagnosed with genital warts or certain precancerous conditions to receive either three injections of the HPV vaccine or a placebo. The women were followed for about four years.

Women who received the vaccine had 46.2 percent lower risk of developing another HPV-related disease after treatment for their genital warts or their precancerous condition.

Typically, women treated for these types of conditions are at risk for subsequent disease later, but the study offers evidence that "vaccination offered substantial benefit" in terms of lowering that risk, wrote the international team of authors, led by Elmar Joura, an associate professor at the University of Vienna in Austria.

Experts not involved with the research told ABC News that the research is significant because it suggests for the first time that the HPV vaccine may offer benefits beyond prevention.

"We always thought about the vaccine from the prevention, and this suggests it can lower the risk of developing a second episode of disease," said Dr. Anna Giuliano, director of the Center for Infection Research in Cancer at the Moffitt Cancer Center in Tampa.

Giuliano cited another study published online in January that found the HPV vaccine reduces the recurrence of abnormal anal cell growths in men.

"We're now seeing a pattern with cervical, vulvar, vaginal and anal dysplasias," she said. "There are prevention effects beyond the first case of disease."

While the findings seem to offer more promise for the HPV vaccine, it's too soon to say whether clinicians will be able to use it for something other than primary prevention of cervical cancer and genital warts in girls and women who have not yet been exposed to the virus through sexual contact.

"It sometimes takes decades to go from HPV infection to pre-invasive disease to cancer, so we're going to need a long period of time before we're going to see cervical cancer prevention or reduction in women who are vaccinated," said Dr. Ursula Matulonis, medical director of medical oncology at the Dana-Farber Cancer Institute in Boston.

Currently, vaccination is recommended for 11 and 12-year-old girls, as well as for girls and women ages 13 through 26, who have not been vaccinated or have not completed the series of vaccines. The Centers for Disease Control and Prevention also recently expanded the recommendations to include 11 and 12-year-old boys. They also recommend that men and boys ages 13 through 21 should also get caught up with their HPV vaccinations.

Page
  • 1
  • |
  • 2
Join the Discussion
You are using an outdated version of Internet Explorer. Please click here to upgrade your browser in order to comment.
blog comments powered by Disqus
 
You Might Also Like...
See It, Share It
A Gilchrist county sheriffs car sits at the end of a trailer home where 7 members of a family were slain by their grandfather in Bell, FL, Thursday, Sept., 18, 2014. The grandfather, Don Spirit, pictured, also killed himself.
Phil Sandlin/AP Photo | Gilchrist County Sheriffs Office
PHOTO:
St. Andre Bessette Catholic Church in Ecorse Michigan
PHOTO: Phoenix police officers escort Arizona Cardinals running back Jonathan Dwyer, to the 4th Avenue Jail following his arrest, Sept. 17, 2014 in Phoenix.
The Arizona Republic, David Kadlubowski/AP Photo